Item 8.01 of this Current Report on Form 8-K.
 
Item 9.01   Financial Statements and Exhibits.
 
(d) Exhibits
  
Exhibit No.     Description
 
99.1  
Press Release dated July 3, 2008
 

 
 
 

 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
                    PROGENICS PHARMACEUTICALS, INC.
                    By:  /s/ ROBERT A. MCKINNEY                            
                               Robert A. McKinney
                                                               Chief Financial Officer, Senior Vice President,
                                                               Finance & Operations and Treasurer
 
 
 
Date:  July 7, 2008